Opportunities and challenges always coexist, as is the case with the current state of equity investment in the primary healthcare market. Although the number and volume of institutional investments have tightened, enthusiasm for corporate financing has waned, and enterprise valuations have shrunk, a new round of changes has accelerated the adjustment and adaptation of equity investment in the primary healthcare market. Investment institutions are moving deeper into early-stage and small-scale investments; innovative niche sectors such as AICG+ healthcare and brain science have become hot topics in the medical industry.

How will the landscape of innovation and investment in the future healthcare industry evolve? In a complex macroeconomic environment, how can investment institutions and enterprises break through existing constraints? Which emerging sectors in healthcare are currently flourishing, and which new technologies have achieved application breakthroughs? Through this forum, we aim to gain insights into the development of the healthcare finance industry, promote deep integration between industry and finance, empower new tracks in medical infrastructure, foster a collaborative innovation investment ecosystem, and drive the advancement of China’s healthcare industry.

November 18, 2023: VB100 Meets You in Beijing—You Are Invited to Participate2023 Future Healthcare Equity Investment Forum & The 5th Future Healthcare Fund Partners (LP-GP) Summit.Themed “Spring Mountains in Sight,” this forum brings together 20+ distinguished guests, 10 major projects, and over 300 industry professionals to connect with frontline healthcare LPs and GPs, jointly exploring market trends under the new economic landscape and engaging in dialogue on cutting-edge investment philosophies and logics.

Register for the Conference

Scan the QR code to register for free

Note: The agenda is for reference only and subject to final on-site confirmation.

VB100 by VCBeat proudly presents the 2023 Future Healthcare Equity Investment Forum and the 5th Future Healthcare Fund Partners (LP-GP) Summit. Rooted in the primary market equity investment ecosystem of the healthcare sector, the forum will extensively connect with leading figures in healthcare equity investment, gathering over 300 high-quality Limited Partners (LPs) and trillions in investable capital. Building on the foundation of the previous four Healthcare Fund Partners Summits, this year’s event will incorporate awards selections and pitch sessions, fostering richer interactive exchanges, more diverse discussion topics, and a more open conference ecosystem. It aims to deeply explore value creation and value investment in the global healthcare industry’s capital markets, while reviewing the past and looking ahead to the future of global healthcare investment.

The topics of this forum are derived from VB100’s industry research. The discussions will focus on the impact of global health challenges on the healthcare sector and how investment can empower solutions to these challenges; explore opportunities in investing in sustainable healthcare solutions, including health sustainability and institutional corporate social responsibility; and examine how emerging technologies are transforming the healthcare landscape, which innovative projects in specific sub-sectors will stand out, and how to integrate investment with innovation to drive new value creation and growth. Led by distinguished guests, all attendees will jointly explore value growth, innovative investment, and sustainable health within a global context.

This VB0 pitch session focuses on four key sectors: pharmaceuticals and biotechnology, high-end intelligent manufacturing and medical devices, upstream pharmaceutical and device supply chain services, and early-stage innovation with technology transfer. Ten selected healthcare innovation projects—namely Jingchuang High-Dimension, Yuanjing Taike, Weinaker, Zhida Pharma, Knowledge Matrix, Shudan Medical, Respilee, Zhida Pharma, Saiyuan Bio, and Zhengzhongji Medical—will deliver live pitches at this VBO event.

（Roadshow Project Details:‍https://mp.weixin.qq.com/s/Pv1QtZ7Btf1so3l9ndudzQ‍)

The roadshow also leverages the top-tier investor resources gathered at the summit, with targeted invitations extended to more than 10 leading professional investment critics for in-depth commentary and diagnostic evaluation of the pitched projects. Currently,Chen Chen, Founder and CEO of Summer Atlantic Capital; Fan Fangfang, Investment Partner of the Medical Division at Guoke Longhui; Li Yingjie, Executive Director at Inno Angel Fund; Su Zhiqiang, Executive Director of the Investment Department at Alibaba Health; Tian Min, Partner at Yuanjing Capital; Wang Xiaoyan, Managing Partner at GSR United Runpu Medical Fund; Wang Yi, Partner at Legend Star; Yang Zhiwen, Founding Partner at Nuoyu Capital; Yu Xiang, Managing Director at CAS Star; Zhang Lehui, Operating Partner at Changling Capital(Listed in alphabetical order by name, not by ranking) Confirmed to attend as commentators. The Organizing Committee is also conducting a targeted call for interactive guests from all investment institutions and will select at least 40 investment interaction participants to engage in live exchanges during the roadshow.

As the year draws to a close, the VB100 List Organizing Committee will leverage the 2023 Future Medical Health Equity Investment Forum to innovate upon the existing “Top 100” framework—specifically the Pengcheng Awards for investment institutions—by designing a new selection program focused on equity investments in medical health. Over a one-month period, the committee will conduct calls for entries and research targeting various equity investment firms that invest in, serve, and empower the high-quality development of China’s domestic medical health industry. Based on detailed, vivid, and specific primary research data, the most representative cases of investment, exit, and empowerment will be selected for the year. Concurrently, the “2023 Future Medical Health Top 10 Investment Institutions Most Welcomed by Innovative Enterprises” selection will also be carried out.

The selection results will be announced at the forum.“2023 Outstanding Cases of Future Healthcare Equity Investment”and“2023 Most Popular Investment Institution Among Innovative Enterprises in Future Healthcare”, will share the stage with representatives from numerous leading institutions to discuss hot investment topics and fundraising collaboration opportunities.